Women who use oral contraceptives (OC) or hormone replacement therapy (HRT) have a two- to sixfold increased risk of a venous thromboembolic event (VTE) compared with nonusers, according to a recent review of available data. Users of OCs containing desogestrel or gestodene, as opposed to levonorgestrel, are at slightly higher risk. And users of OCs or HRT who carry an inherited hypercoaguable state are at exponentially higher risk.
Vaginal hysterectomy is about four times more likely to fail in women with a narrow pubic arch than in others, according to a prospective cohort study of 75 women.
In women who carry BRCA1 or BRCA2 mutations, MRI is more sensitive for detecting breast cancers than mammography, ultrasound, or clinical breast exam (CBE) alone, but whether this translates into reduced mortality is still unknown. This is according to the results of a surveillance study involving 236 Canadian women between the ages of 25 and 65.
Lasofoxifene is the first selective estrogen receptor modulator (SERM) to help vaginal atrophy, says a multicenter trial presented at the 15th Annual Meeting of the North American Menopause Society (NAMS). Investigators found the drug reduced dryness with few side effects.
Celiac disease-once believed to be rare-actually affects up to 1% of the US population. So underdiagnosed is the problem that the National Institutes of Health convened a consensus panel, which recently announced recommendations for appropriate diagnosis and management of the disease.
The sensitivity and specificity of screening mammography is lower in women taking hormone replacement therapy (HRT), those who have had breast surgery, and those who are thin, according to results from a sample of women from the Million Women Study.
While many hoped that ductal lavage might provide a means for detecting breast cancer sooner in women at high risk for the disease, a recent study finds that the method isn't as useful as we had hoped.
When neurologic injury occurs despite following all the right medical procedures, a no-fault compensation system may be the best way to handle the situation.
Many women have sexual dysfunction, and effective treatments are available for some conditions. Routinely discussing sexual function with your patients, and their partners, is important because dysfunction truly is a couples issue.
In June 2000, I arrived a few minutes late to the American College of Obstetricians and Gynecologists' headquarters for a meeting of the Committee on Obstetric Practice. As Chair, I was used to dealing with political hot potatoes, but that day, I was handed a real sizzler. Earlier that morning, then ACOG president, Benjamin Harer, MD, speaking for himself and not the College, had seemingly endorsed "elective" cesarean deliveries (CD) in an interview with Diane Sawyer on "Good Morning America." After watching an excerpt of the interview in which Dr. Harer debated a non-physician advocate of home VBACs attended by midwives, I was struck by the logic of his arguments and his grace under fire. Yet it fell to my committee to restate ACOG's official position against such surgeries, which we did in a press release
"Misinformation about toxoplasmosis is widespread," according to Patrick Duff, MD, Department of Obstetrics and Gynecology at the University of Florida.
Your patient has a twin gestation at almost 29 weeks and one of the fetuses has IUGR. How should you proceed?
Last month, I reviewed the factors that have driven the dramatic increase in cesarean delivery (CD) rates over the past several years. This month, I'll review the potential impact of this trend on a "typical" obstetric service. While both staff and physical capacity will be taxed by increased CD rates, I believe that patient safety may also be threatened as a result of the incremental demand on limited obstetrical operating room (OR) availability. I offer several strategies to manage the coming chaos.
It's imperative to identify more HIV-infected women earlier in pregnancy through HIV testing and to reduce mother-to-child transmission of the virus that causes AIDS.
It's hard to imagine a more serious crisis than the current legal liability debacle facing American ob/gyns. Dr. Charles Lockwood has gathered the profession's thought leaders to help analyze its complexities and discuss possible solutions.
Learning that she has what used to be called premature menopause can devastate a woman in her 20s or 30s. Diagnose this mysterious condition without delay, deliver the bad news in person, and provide sensitiveanswers to four basic questions.
Using reproductive and genetic technologies to provide prospective parents with information about a future child or to avoid having a child with a genetic abnormality is an emerging field of medicine-one that has its share of legal risks, according to a report entitled "Reproductive Genetics and the Law."
If a patient on hormonal contraceptives (HC) is complaining about lack of interest in sex, one of the first things to think about is stopping her contraceptive.
While the Women's Health Initiative questioned the value of long-term HRT in preventing cardiovascular disease (CVD), a new analysis of the raw data presented at the annual ASRM meeting in Philadelphia strongly suggests that long-term use of OCs does protect a woman's heart, and reduces the threat of cancer.
In a recent issue of Lancet, researchers reported on one of the first successful cases in which ovarian tissue that had been removed and frozen before a patient underwent cancer chemotherapy was later re-implanted and led to a successful pregnancy.